Navigation Links
Neurocrine Biosciences Reports Second Quarter 2011 Results
Date:7/28/2011

5,965

6,315Cease-use expense76

134

176

281Total operating expenses11,061

10,533

21,634

21,455Income (loss) from operations1,096

(5,890)

3,035

(16,059)Other income:Gain on sale/disposal of assets18

53

98

168Deferred gain on real estate737

715

1,473

1,430Investment income and (expense), net120

(65)

239

614Other income, net5

35

13

59Total other income880

738

1,823

2,271Net income (loss)$  1,976

$  (5,152)

$  4,858

$  (13,788)Net income (loss) per common share:Basic$  0.04

$  (0.09)

$  0.09

$  (0.27)Diluted$  0.04

$  (0.09)

$  0.09

$  (0.27)Shares used in the calculation of net income (loss) per common share:Basic55,209

54,836

55,097

50,750Diluted56,434

54,836

56,276

50,750NEUROCRINE BIOSCIENCES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) June 30,
2011December 31,
2010Cash, cash equivalents and short-term marketable securities

$  115,160

$  126,865Other current assets

4,878

6,186Total current assets

120,038

133,051Property and equipment, net

1,263

1,532Long-term investments

3,739Restricted cash

6,104

6,102Total assets

$  127,405

$  144,424Current liabilities

$  49,990

$  52,777Long-term liabilities

51,857

72,302Stockholders' equity

25,558

19,345Total liabilities and stockholders' equity

$  127,405

$  144,424
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
2. Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
3. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
4. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
5. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
6. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
7. Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix
8. Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
10. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
11. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 Research and Markets has ... Microcrystalline Cellulose Industry Report 2014" report to their ... Cellulose Industry Report 2014 is a professional and in-depth ... cellulose industry with a focus on the Chinese situation. ... the industry including definitions, classifications, applications and industry chain ...
(Date:9/22/2014)... and TORONTO , Sept. ... www.generex.com ) (OTCBB:GNBT) today announced that it has ... (UHN) pursuant to which UHN,s Centre for Molecular ... buccal insulin refinement project.  The goal of the ... Generex Oral-lyn™, the Company,s proprietary buccal insulin spray ...
(Date:9/22/2014)... FierceBiotech today announced its annual “Fierce ... of 2014. FierceBiotech editors John Carroll and Damian ... winners. Those selected are identified as some of ... , "It's always a lot of fun ... companies," said Carroll. "This year in particular you'll find ...
(Date:9/22/2014)... , September 22, 2014 ... on a mixed note as the Dow Jones Industrial ... Composite closed at 4,579.79, down 0.30%. The S&P 500 ... trading session, six out of ten sectors finished on ... Index ended the day at 751.48, up 0.10%, with ...
Breaking Biology Technology:Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Generex Collaborates with University Health Network for Buccal Insulin Project 2Generex Collaborates with University Health Network for Buccal Insulin Project 3Generex Collaborates with University Health Network for Buccal Insulin Project 4FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5
... Walsh College Troy ... , , TROY, Mich., June 2 Walsh College ... teamed up to offer a new series of Walsh College,s successful "Take Charge" ... features more days, more topics and expanded career content. All are provided ...
... BMRN ) today announced that Jean-Jacques Bienaime, Chief Executive ... Sachs 30th Annual Global Healthcare Conference in New York City on ... , Interested parties may access a live audio webcast of ... www.BMRN.com . A replay of the call ...
... techniques proven cost-effective, Genomatica looks to develop demonstration ... Genomatica, a sustainable chemicals company, announced today ... important milestone toward the production of commercial grade ... bioprocess. The company has demonstrated that it ...
Cached Biology Technology:Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of 'Take Charge' Workshops for the Unemployed 2Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of 'Take Charge' Workshops for the Unemployed 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of 'Take Charge' Workshops for the Unemployed 4BioMarin to Present at the Goldman Sachs Healthcare Conference 2Genomatica Produces Pure BDO From Natural Sugars 2Genomatica Produces Pure BDO From Natural Sugars 3Genomatica Produces Pure BDO From Natural Sugars 4
(Date:9/18/2014)... Mass. A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... The ability to acquire and creatively manipulate spoken language ... over the past 6 million years of human evolution ... is the best candidate gene we now have," says ... LMU. In his efforts to understand the molecular biological ... step forward. The results of his latest study, undertaken ...
(Date:9/18/2014)... Dogs generally seem to be cheerful, happy-go-lucky characters, so ... outlook on life. , In fact some dogs ... University of Sydney shows. , "This research is ... in dogs objectively and non-invasively. It offers researchers and ... and how that changes," said Dr Melissa Starling, from ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3Dogs can be pessimists too 2Dogs can be pessimists too 3
... Ore. A 700-mile security wall under construction along ... the movement and "connectivity" of wildlife, biologists say, and ... of some species. However, technology and alterations to ... to move more freely between the two countries, the ...
... survival is now better understood. For the first time, ... National Laboratory observed the chemical changes in individual cells ... them. The team tracked the chemical changes in ... can only exist in an oxygen-free environment. They exposed ...
... A Purdue University scientist has discovered a key process in ... Xiaoqi Liu, an assistant professor of biochemistry, found that ... during cell growth, as well as a shortage of the ... laboratory showed that the Plk1 molecule indirectly attacks p53 in ...
Cached Biology News:US-Mexico border wall could threaten wildlife species 2US-Mexico border wall could threaten wildlife species 3US-Mexico border wall could threaten wildlife species 4Scientists track chemical changes in cells as they endure extreme conditions 2Scientists track chemical changes in cells as they endure extreme conditions 3Protein can help cells or cause cancer, Purdue researcher finds 2
... Ambions 96 well Magnetic-Ring Stand is ... 96 well U-bottom microplates. The stand has ... 96 well microtiter plate footprint. The use ... enables fast and easy magnetic separation. With ...
... from Thermus aquaticus expressed in E. coli; ... of 250 units enzyme/tube and Buffer I ... the same enzyme as AmpliTaq DNA Polymerase ... separation process to ensure that contaminating bacterial ...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
... is a versatile and easy-to use enzyme, ... GCpro Taq DNA Polymerase is prepared from ... containing the DNA polymerase I gene from ... processive 5'-3' DNA polymerase activity. Its inherent ...
Biology Products: